Aggressive_peripheral_T-cell_lymphomas_containing_Epstein-Barr_viral_DNA:_a_clinicopathologic_and_molecular_analysis._The_Epstein-Barr_virus_(EBV)_has_been_shown_to_be_associated_with_posttransplant_lymphoma,_Hodgkin's_disease,_and_T-cell_lymphoma,_in_addition_to_African_Burkitt's_lymphoma._In_a_retrospective_study_of_56_consecutive_cases_of_T-cell_lymphoma,_EBV_DNA_was_found_by_Southern_blot_and_in_situ_DNA_hybridization_in_10_(20%)_of_50_peripheral_T-cell_lymphomas,_but_in_none_of_six_cases_of_T-lymphoblastic_lymphoma._Peripheral_T-cell_lymphomas_containing_EBV_DNA_could_be_subclassified_into_three_categories_according_to_histology_and_immunophenotypic_studies:_(1)_T-cell_lymphoma_of_the_helper_phenotype,_five_cases._Two_cases_had_histologic_features_resembling_angioimmunoblastic_lymphadenopathy_(AILD)._(2)_T-cell_lymphoma_of_the_cytotoxic/suppressor_phenotype,_four_cases._AILD-like_features_could_also_be_recognized_in_two_cases._Reed-Sternberg-like_giant_cells_were_identified_in_three_cases_designated_Hodgkin-like_T-cell_lymphoma._(3)_Angiocentric_T-cell_lymphoma_or_lymphomatoid_granulomatosis_in_one_case,_initially_affecting_the_skin_and_nose;_no_T-cell_subset_could_be_defined._Six_of_the_eight_EBV_DNA-positive_patients_tested_for_serum_EBV_antibodies_had_elevated_titers_of_IgG_antiviral_capsid_antigen_(greater_than_640)_and/or_early_antigen_(greater_than_10)._From_combined_studies_of_Southern_blot_hybridization_by_using_EBV_termini_fragment_probe_and_in_situ_DNA_hybridization,_the_EBV_genomes_appeared_to_be_clonotypically_proliferated_in_the_neoplastic_T_cells._The_patients_in_all_three_groups_usually_had_prolonged_fever_preceding_the_diagnosis,_hepatosplenomegaly,_an_aggressive_clinical_course,_and_poor_response_to_chemotherapy;_nine_died_with_a_median_survival_of_only_8_months._We_propose_that_these_EBV-associated_aggressive_T-cell_lymphomas,_like_human_T-cell_leukemia/lymphoma_virus-positive_T-cell_lymphoma,_have_characteristic_clinicopathologic_features_and_should_be_treated_as_a_separate_disease_entity.